Britain, Economic, Government, Health, Politics

Politically the NHS is non-negotiable. That has to change.

NATIONAL HEALTH SERVICE

Intro: The philosophy and funding model for the NHS is not fit for the 21st century. To fix it, we first need to admit that the NHS is broken

THE centrepiece of the opening ceremony of the 2012 London Olympic Games was a celebration of the NHS. This was understandable: the host country was projecting a healthcare system that is uniquely British.  

In this case, however, a description of “unique” says something deeply worrying. For it is uniquely British only because no other country has ever sort to copy or replicate it. The world was watching that Olympic opening ceremony, but no other country looked at those medics dancing energetically around the beds of their smiling patients and concluded that this was an institution they wanted to introduce into their own countries.

It is surely reasonable to ask, why not? And what does that say about the NHS?

There is no doubt that much of the public adoration of the NHS is founded on fading folklore memory of pre-1948 Britain when millions of people suffered illness and premature death because they could not afford to pay for a doctor. That obscenity cast a long shadow, but it’s time to consign such memories to the archives of history.

Most other countries, after all, have very similar histories. Britain was not unique in its suffering from appalling health inequalities in the past, or in its strident attempts to seek a better, more equitable way of looking after the health needs of its post-war population. Other nations faced the same challenges, and they arrived at different solutions.

But in Britain there can be no solutions other than the one that Nye Bevan, the Welsh MP who served as health secretary in the post-war Labour government, came up with more than 75 years ago.

We may live in a world transformed, a globalised world of advanced technologies undreamed of in the past century, a world of instant communication, high-powered algorithms, and artificial intelligence, but when it comes to health policy, Nye’s unflinching word is the secular equivalent of holy writ set in tablet and stone.

And heretics who doubt his word by quickly casting to the wind any suggestion of fruitful reform are castigated as malign. But maybe, just maybe, not everything the NHS does, and the way certain things are done, are perfect. Perhaps there are alternative ways of funding it, and that there might be lessons to be learned from the way other modern democracies provide healthcare for their own citizens.

Such is the current state of debate – stifled at every opportunity – and, yet the NHS is arguably the most important institution in the country. Funding has never been unlimited; the system has been stretched to its limits in recent years, resources are inefficiently allocated, and the country is still expected to provide a healthcare system for everyone based on 1948 ideals.

The combined cost of health services in England and Scotland is nearly £200billion a year. Despite this, still one in seven Scots languish on waiting lists for treatment. Economists predict that the funding crisis is only going to get worse as our population ages.

Why shouldn’t we be addressing these issues in a full and frank public debate? It would, after all, be in the interests of hard-pressed taxpayers’ who fund in full NHS services and provision.  

But every time politicians even raise the possibility of doing things differently, they are shouted down, accused of wishing to “privatise” the NHS or – worse – introduce an American style service that only the wealthy can afford, leaving the vast majority of people in Britain at the mercy of exploitative private health insurance companies.

And so, the unsustainable status quo goes on, with our political parties too frightened to explain exactly how they will address the demographic time bomb that is looming.

There are only two politically acceptable “solutions” to what now seems like a permanent NHS crisis: more funding – and even more funding.

Our politicians need to be slightly braver by showing some courage, by being more imaginative, and less terrified of incurring a disapproving look from voters. They need to be honest about the challenge we all face.

They would concede that a funding and organisational model brought into being a matter of months after the defeat of the Nazis, might not necessarily be the right model for healthcare in the third decade of the 21st century.

Could it be that any constructive criticism of the NHS, or any new thinking about alternative ways of funding healthcare, are shouted down because the arguments for maintaining the status quo are too fragile to withstand robust scrutiny?

TWO

WHY, then, faced with criticism of the NHS, do its defenders seek falsely to claim that the only choice is between what we already have and the admittedly dreadful service that American citizens must tolerate?

Why not admit that there are plenty of other health services in the world – systems that use a variety of funding mechanisms? And that many of them have better health outcomes than in the UK? Is it seriously being suggested that Britain has nothing to learn from those other countries?

The facts do not come any clearer. Britain comes nowhere near the top of league tables when international comparisons for cancer and cardiovascular survival rates are compiled. We even fall behind the United States on many metrics.

In a country whose society has been so fractured by our public debate about Brexit, it is extraordinary that even the most ardent Remainers, those who insist that the EU is better, more progressive, more caring, more tolerant than the insular, old fashioned, short-termist Britain, will draw the line at healthcare. We should all be more European in every aspects of our lives, they say, except when it comes to healthcare.

Germany, for example, has a healthcare system funded by a combination of public funds and private insurance. Its health outcomes, including life expectancy, puts Britain to shame.

The country has a public health system, but it’s financed in a radically different way from the NHS. Around 86 per cent of Germans are enrolled in schemes run by not-for-profit insurance organisations known as sickness funds. They choose which fund they sign up to.

These are paid for by deductions from wages with employee and employer contributions. Some small out-of-pocket payments are required for hospital visits and medicines.

The healthcare system in Germany is also better staffed than it is in the UK, relative to the population. Analysis by the Nuffield Trust in 2019 concluded that the UK had around nine nurses per 1,000 people, while in Germany there were about 14. The disparity in bed numbers was wider too, with Germany’s eight beds per 1,000 more than three times the UK figure.

In France, the healthcare system is funded by social security contributions, central government funding, and partly by patients themselves, who have to pay a percentage of costs for medical treatment or prescription drugs. Like the UK, France provides healthcare to every resident regardless of age, income, or status. But life expectancy for French women is the second highest in the world.

The healthcare system in Italy, also provided through a mixed public-private system, is considered one of the finest in the world.

Worryingly, a recent report by the King’s Fund concluded that Britain’s life expectancy rates are among the lowest in Europe.

As local health surgeries struggle to cope with the aftermath of the Covid pandemic, the dreaded 8am rush to get a GP appointment has become the bane of most people in this country. And every winter heralds a new crisis of hospital bed shortages.

And still the NHS is plagued by industrial action by nurses and junior doctors, who feel they are unrewarded, and have become cynical about their working practices and conditions of employment.

THREE

ACCORDING to the Organisation for Economic Cooperation and Development (OECD), the UK spends more on healthcare than comparable countries (about 11.3 per cent of GDP in 2022), but has fewer hospital beds and diagnostic tools, and pays nurses less.

Across the countries studied by the OECD in 2021, there were on average 4.3 hospital beds for every 1,000 in the population. But in the UK the figure was only 2.4 beds for every 1,000. Only Mexico, Costs Rica, Columbia, Chile, and Sweden, reported lower ratios.

So, what, if anything, can be done to improve things?

The first course of action should be to decide not to rule anything out. And yet that’s exactly what our politicians have always done.

Even when solutions are staring them in the face, they will insist that if it’s never been part of the NHS before, then it shouldn’t be in the future either. Even when other countries have successfully tried and tested those exact solutions.

The UK needs to be wiser about how to spend scarce resources. Every so often, a brave politician will tentatively suggest that patients should pay a small sum towards their GP appointments, or even be fined for failing to keep an appointment. But they are soon shouted down and told to behave themselves on pain of deselection or electoral defeat. The NHS is a political bargaining chip that is so entrenched with the electorate that political parties cannot budge over. Any governing party holds it as sacrosanct.

In Scotland, the introduction of free prescriptions for all was a major boost to the incomes of those already wealthy enough to pay for medicines. But woe betide any political party that might seek to reverse this redistribution of wealth from the poor to the rich.

Switching to a European-style social health insurance system would be no panacea – what works in one country could not be expected to work precisely the same way elsewhere.

But what does it say about the state of public debate in Britain that such a reform is immediately dismissed as being beyond the pale?

Germany, France, and Italy are hardly basket cases, or third world countries. Until two years ago, they were among our most important EU trading partners.

The question for policymakers should not be how best to preserve the NHS as it is, but rather how patients’ interests be prioritised?

The NHS was created to serve the country, not the other way around. It is not there to provide employment for its million-plus workforce. It is not there to create jobs for an army of administrators and bean counters.

And it certainly doesn’t exist to provide well-paid work for diversity, equity and inclusion officers, whose numbers have exploded in recent years with no measurable improvement in the quality of care given to patients as a result.

It exists for us, the UK citizens who pay for it with our taxes. That is its primary, if not its sole, function. And as the funders of the NHS, we should be insisting that it is no longer run in the shadow of a past that is viewed through rose-tinted glasses.

We should demand that it becomes a modern, flexible, dynamic, and innovative service.

We could start by shattering a central shibboleth of faith in the NHS: that privatisation is somehow alien to it, with its only aim to make profits from vulnerable patients.

In fact, the private sector is an essential mechanism for providing essential health services. Opticians and dentists, for example, earn much of their income from privately paying patients.

FOUR

EVEN local GP practices, our primary interface with the health service, are essentially private companies contracted to provide services to the NHS. No one in this country gets through life without dealing, at one point or another, with a private provider of healthcare services.

Institutional and financial reforms are necessary and inevitable at some point. But we as ordinary citizens must shoulder some of the responsibility for helping improve the nation’s health.

Far too often we have allowed politicians to convince us that our poor health – whether from being overweight, drinking too much alcohol, not taking enough exercise, or smoking – is not our responsibility, but is the fault, somehow, of the Government, or the food industry, or advertisers.

We are told to believe that we are powerless, susceptible to the diktats of these external forces.

We eat too much because planning laws allow too many fast-food restaurants to be built. We eat fatty, processed foods because we were never taught to cook properly at school. Many people smoke because they’re influenced by Hollywood stars doing the same on screen.

It’s all a big, dangerous lie. We choose what to eat and what lifestyles to pursue. If we rely on the Government to tell us how to live and to intervene to force us to make better choices, we surrender all responsibility for our own lives and our own health.

The combination is lethal. We rely on the Government to govern how we live and what we eat, and then demand that the health service we pay for through our taxes delivers better results, even as we rule out any kind of radical reform that might improve that healthcare system.

Standard
Health, Medical, Research, Science

Blood test that can detect Alzheimer’s 15 years before onset

ALZHEIMER’S DISEASE

A SIMPLE blood test can detect Alzheimer’s disease up to 15 years before symptoms begin, a major trial has found. It paves the way for a national screening programme.

The trial found that the test was as accurate as the current gold standard for diagnosing the condition.

For the first time, doctors were able to say if a person had a high, medium, or low chance, of having the disease – ruling out further invasive procedures.

Experts have said it would “revolutionise” diagnosis, making Alzheimer’s as easy to test and detect as for other routine health conditions such as high cholesterol.

Patients could expect results within days of visiting their GP, rather than the years it currently takes to get a diagnosis. This could have huge implications for future treatments, removing the barriers for a diagnosis – such as long waits for spinal taps or brain scans – and speeding up trials.

It could also pave the way for screening over-50s once more effective treatments become available.

Made by diagnostics company ALZpath, it was found to be 97 per cent accurate at detecting traces of the “tau” protein, which was linked to developing Alzheimer’s disease during the eight-year trials. These proteins start to build up on the brain 10 to 15 years before symptoms start showing.

Researchers in Sweden found high levels of the “tau” protein in the blood test corresponded to high levels of Alzheimer markers seen in expensive diagnostic brain scans and painful lumbar punctures.

The more of this leaked “tau” brain protein in the blood, the more likely or advanced the Alzheimer’s disease was in the tests involving 786 people. Growing evidence suggests biomarker changes like these can be detected in the blood years before other signs of the disease appear in the brain.

It means if scientists can find a way to stop these protein levels from rising, they could effectively halt Alzheimer’s in its tracks.

With breakthrough treatments such as donanemab and lecanemab on the horizon, experts say it is vital to have quick and reliable diagnoses. Professor David Curtis of University College London Genetics Institute said this was “one half of the solution”, while we await effective treatments.

He added: “This potentially could have huge implications. Everybody over 50 could be routinely screened every few years, in much the same way as they are now screened for high cholesterol.”

Around 900,000 people in the UK live with dementia – with Alzheimer’s the most common form. The growing ageing population means numbers are expected to rise to 1.6million by 2040, making a cheap screening tool vital to get to grips with the challenge.

Alzheimer’s Research UK analysis found 74,261 people died from dementia in 2022 compared with 69,178 a year earlier, making it the country’s biggest killer. While previous blood tests have shown promise, these findings have caused particular excitement given the high accuracy levels, large study size, and because the test already exists commercially.

It is also the first time a blood test has been found to be at least as good as a painful lumbar puncture or spinal tap for detecting elevated levels of the tau protein, according to the research team at the University of Gothenburg, Sweden.

Lumbar punctures involve taking fluid from the patient’s spinal cord. The inexpensive tests – priced at around £150 – could also be used to monitor a patient’s condition, allowing more tailored trials or treatment in future.

Dr Richard Oakley, of the Alzheimer’s Society, urged that more research would be needed, but said: “This study is a huge welcome step in the right direction as it shows that blood tests can be just as accurate as more invasive and expensive tests.

“It suggests results from these tests could be clear enough to not require follow-up investigations for some people living with Alzheimer’s disease, which could speed up diagnosis.”

The tests would need regulatory approval before widespread use. But they could form part of NHS trials starting imminently and looking to roll out blood tests for Alzheimer’s within the next five years.

The scientists’ findings were first published in JAMA Neurology.

Standard
Health, Science, Society, United Nations, World Health Organisation

Global cases of cholera are on the rise

CHOLERA

CASES of cholera are increasing, with 22 countries around the world experiencing an outbreak. After many years of decline, incidences rose in 2022 due to vaccine shortages, climate change and escalating conflict. It is a trend that is expected to continue.

. Science Book

Some 26,000 cholera cases were reported in Africa during the first 29 days of January 2023. This is already 30 per cent of the continent’s total in 2022. At the end of February, the World Health Organisation (WHO) said that more than 1 billion people across 43 countries are at risk.

Overall, Malawi appears to be the worst-hit country, with the highest number of deaths. It reported just under 37,000 cholera cases and 1,210 fatalities from 3 March 2022 to 9 February 2023.

This was triggered by a cyclone that hit in March 2022. This led to wastewater contaminating drinking water supplies.

Cholera is spread by the ingestion of food or water that is contaminated with the bacterium Vibrio cholerae. When it enters the body, some types of V. cholerae release a toxin that interacts with the cells lining the surface of the intestine, leading to diarrhoea.

In some cases, this can result in severe dehydration and death. In Malawi, 3.3 per cent of people with cholera die of the infection. With treatment, this is typically around 1 per cent.

In 2022, Malawi vaccinated millions of people in districts that were facing cholera outbreaks, but the cyclone has allowed the disease to spread to all of its districts, putting unvaccinated people at risk.

Extreme weather, driven by climate change, means many more countries are at risk of wastewater contamination. Cyclone Freddy, which hit Mozambique on 24 February, is expected to exacerbate the country’s cholera outbreak.

Climate change-driven droughts in countries such as Kenya and Ethiopia have also forced people to rely on water sources that may be contaminated with V. cholerae, according to UNICEF. Many people in these regions are malnourished, which affects their immune health, leaving them more vulnerable to severe cholera complications.

Displacement, whether due to conflict in countries like the Democratic Republic of the Congo or disasters such as the earthquake that hit part of Syria on 6 February, can also play a role in cholera outbreaks if people are forced to move to less sanitary areas, or if already infected people take the bacteria with them.

The destruction of health facilities and infrastructures [in Syria] that bring water to people could lead to more cases. According to the United Nations, the country reported more than 37,700 suspected cases in the cities of Idlib and Aleppo from 25 August 2022 to 7 January 2023 – 18 per cent of which were in people in displaced camps.

The unprecedented scale of the cholera outbreaks in 2022 – with 30 countries reporting cases, compared with an average of fewer than 20 in the previous five years – has also depleted global vaccine supplies. Only 37 million doses are available.

The International Coordinating Group on Vaccine Provision, which manages the WHO’s global vaccine stockpile, therefore recommends that at-risk people be vaccinated with a single dose of a cholera vaccine rather than the typical two doses. The one-dose regimen gives only about one year of protection, compared with three years with two doses. If the outbreaks continue as they are, this year of protection might not be enough time to get them under control.

Cholera has always been an issue, which prompted the UN to publish a road map in 2017 to cut 90 per cent of cholera deaths globally by 2030.

Several countries have made progress. The fact that Malawi has detected cholera outbreaks so quickly points to the work that officials have done to increase health surveillance.

But with just seven years to go until 2030, many aren’t convinced that the UN’s target will be reached. They say there hasn’t been enough investment in water infrastructure around the world to reach those goals.

Standard